Skip to Main Content

Browse issues

Volume 50, Issue 10, October 2020

Review

Tomoya Yokota and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 10, October 2020, Pages 1089–1096, https://doi.org/10.1093/jjco/hyaa139

Immune checkpoint inhibitors play a crucial role in the strategy for treating squamous cell carcinoma of the head and neck.

Tomokazu Kimura and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 10, October 2020, Pages 1097–1107, https://doi.org/10.1093/jjco/hyaa155

This review article summarized the evidence and on-going clinical trials of bladder preservation therapy for muscle invasive bladder cancer in the past and future immuno-oncology era.

Original Articles

Basic Research

Yanmei Zhang and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 10, October 2020, Pages 1108–1116, https://doi.org/10.1093/jjco/hyaa089

Metastatic patient-derived xenograft mouse models for colorectal cancer were established with shorter time and higher success rate. And they retained the dominant characters of the original patient tumours.

Hepato-biliary and Pancreatic Medicine

Guoping Jiang and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 10, October 2020, Pages 1117–1125, https://doi.org/10.1093/jjco/hyaa088

Gene mutations of 63 cholangiocarcinoma patients were evaluated. We found that intrahepatic cholangiocarcinoma frequently occurred in young patients, and BAP1 and LRP2 could be biomarkers for Chinese intrahepatic cholangiocarcinoma patients.

Epidemiology/Public Health

Osamu Hemmi and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 10, October 2020, Pages 1126–1132, https://doi.org/10.1093/jjco/hyaa104

With decreased smoking rates and aging of the population, lung cancer screening may be better targeted to a smaller at-risk population.

Jiqing Li and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 10, October 2020, Pages 1133–1140, https://doi.org/10.1093/jjco/hyaa103

We developed and externally validated a Super learner-based model for patients with Stage I–III colorectal cancer, which could provide the probability of death from colorectal cancer in patients with resected colorectal cancer.

Gastrointestinal Surgery

Chuan-bing Cheng and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 10, October 2020, Pages 1141–1149, https://doi.org/10.1093/jjco/hyaa099

Lymphocyte-to-C-reactive protein ratio, a novel immune inflammation-based score (IBS), superior to other IBS, could more accurately predict post-operative morbidity and prognosis of gastric cancer.

Gynecology

Won Kyung Cho and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 10, October 2020, Pages 1150–1156, https://doi.org/10.1093/jjco/hyaa091

The para-aortic lymph node evaluation was not associated with better survival in patients with International Federation of Gynecology and Obstetrics IIIC1p cervical cancer who were clinically para-aortic lymph node-negative.

Yusuke Kobayashi and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 10, October 2020, Pages 1157–1161, https://doi.org/10.1093/jjco/hyaa098

We retrospectively investigated the institution’s outpatient flexible hysteroscopy cases. It is highly safe, with a slight negligible effect on ascites cytology. However, the diagnosis should be determined by multidisciplinary approaches.

Head & Neck

Takeshi Shinozaki and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 10, October 2020, Pages 1162–1167, https://doi.org/10.1093/jjco/hyaa087

Surveillance of the head and neck regions after endoscopic resection of esophageal cancer is required to detect second primary head and neck cancers at an early stage, thereby facilitating a minimally invasive treatment.

Orthopedics/Sarcoma

Toshihide Hirai and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 10, October 2020, Pages 1168–1174, https://doi.org/10.1093/jjco/hyaa100

Palliative and Supportive Care

Tomoko Matsui and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 10, October 2020, Pages 1175–1181, https://doi.org/10.1093/jjco/hyaa086

This study investigated the actual status of the utilization of such services and examined the related factors of their use using the transtheoretical model.

Radiation Oncology

Pervin Hurmuz and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 10, October 2020, Pages 1182–1187, https://doi.org/10.1093/jjco/hyaa093

We evaluated our SBRT treatment results for patients with early-stage NSCLC using two different motion management systems. We have not found any difference in treatment outcomes in the whole cohort. Interestingly, we found that beam-on time might significantly affect treatment outcomes.

Katsumasa Nakamura and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 10, October 2020, Pages 1188–1194, https://doi.org/10.1093/jjco/hyaa111

A national survey on the current status of for hormone-naïve prostate cancer with bone metastases identified radiation oncologists’ attitudes and practice patterns of radiotherapy in Japan.

Thoracic Medicine

Yasuyuki Onishi and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 10, October 2020, Pages 1195–1200, https://doi.org/10.1093/jjco/hyaa106

Pulmonary epithelioid hemangioendothelioma showed three computed tomography patterns: multiple small nodules pattern, multiple nodules with large lesions pattern and single lesion pattern. Patients with pulmonary epithelioid hemangioendothelioma have good prognosis.

Urology

Kosuke Kojo and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 10, October 2020, Pages 1201–1208, https://doi.org/10.1093/jjco/hyaa110

The mean age of testicular germ cell tumor patients is nearly 40 years. The proportion of older testicular germ cell tumor patients and testicular lymphoma patients was higher than previously thought.

Clinical Trial Note

Ryo Shimoyama and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 10, October 2020, Pages 1209–1213, https://doi.org/10.1093/jjco/hyaa107

This trial aimed to confirm the superiority of anatomical segmentectomy over wedge resection in terms of overall survival in high-risk operable patients with clinical stage IA non-small cell lung cancer.

Cancer Genetics Report

Shodai Takahashi and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 10, October 2020, Pages 1214–1217, https://doi.org/10.1093/jjco/hyaa095

Lung adenocarcinoma arising in a Li–Fraumeni syndrome patient, bearing germline mutation, R333Vfs*12 of TP53, is sensitive to epidermal growth factor receptor-tyrosine kinase inhibitors, such as gefitinib and osimertinib.

Epidemiology Note

Megumi Hori and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 10, October 2020, Pages 1218–1224, https://doi.org/10.1093/jjco/hyaa094

Lifetime cumulative mortality risks differed greatly according to smoking status. The results of this study may be useful for the development of tailored prevention programs.

Letter

Shihong Ren and Zhan Wang
Japanese Journal of Clinical Oncology, Volume 50, Issue 10, October 2020, Page 1225, https://doi.org/10.1093/jjco/hyaa101
Shoichiro Tani and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 10, October 2020, Page 1226, https://doi.org/10.1093/jjco/hyaa102

Image of the Month

Naoki Hirano and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 10, October 2020, Pages 1227–1228, https://doi.org/10.1093/jjco/hyaa046

Cancer Statistics Digest

Eiko Saito and Megumi Hori
Japanese Journal of Clinical Oncology, Volume 50, Issue 10, October 2020, Pages 1229–1230, https://doi.org/10.1093/jjco/hyaa175
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close